Hidradenitis Suppurativa Market Growth, Trends, and Forecast 2025 | Top key players - Pfizer Inc., Eli Lilly and Company, AbbVie Inc.

The Global Hidradenitis Suppurativa Market reached USD 725.6 million in 2022 and is projected to witness lucrative growth by reaching up to USD 1.1 billion by 2031. The Global Hidradenitis Suppurativa Market is expected to exhibit a CAGR of 4.8% during the forecast period 2024-2031.

Hidradenitis Suppurativa Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

Hidradenitis Suppurativa (HS) is a chronic skin condition causing painful lumps, abscesses, and tunnels under the skin, typically in areas where skin rubs together, like the armpits and groin. It leads to recurrent flare-ups, affecting quality of life. The HS market focuses on treatments aimed at managing symptoms, improving patient comfort, and preventing disease progression.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/hidradenitis-suppurativa-market?sz

Market Opportunities and Growth Drivers:

Increasing FDA approval of products is driving the Global Hidradenitis Suppurativa Market growth.

FDA Approves Adalimumab-Aaty, Celltrion's High-Concentration Biosimilar of Humira
In May 2023, Celltrion USA announced that the FDA approved Adalimumab-aaty, a biosimilar to Humira (adalimumab) with a high concentration (100 mg/mL) and no citrate. This approval covers a wide range of conditions, including hidradenitis suppurativa, rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis.

Yuflyma: A New Anti-TNF Biosimilar Offering Greater Flexibility for Patients
Yuflyma, Celltrion's second anti-TNF biosimilar approved in the U.S. and the company's sixth overall, is now available to patients. This biosimilar provides new treatment options with pre-filled syringes and autoinjector administration alternatives, catering to various patient preferences. Yuflyma's high-concentration, citrate-free formulation offers an effective and patient-friendly therapeutic option, expanding choices for those seeking treatment for inflammatory conditions.

Hidradenitis Suppurativa Market Recent Development:

UCB Reports Positive Phase 3 Results for Bimekizumab in Hidradenitis Suppurativa Treatment

In March 2023, UCB, a global biopharmaceutical company, shared promising results from two Phase 3 studies (BE HEARD I and BE HEARD II) evaluating bimekizumab for the treatment of moderate to severe hidradenitis suppurativa (HS). The results highlighted the drug's efficacy and safety, offering hope for individuals living with this challenging and painful skin condition.

MoonLake Immunotherapeutics Accelerates Clinical Trial for Sonelokimab in Hidradenitis Suppurativa

In February 2023, MoonLake Immunotherapeutics AG, a clinical-stage biotech company, announced that its global Phase 2 clinical trial for sonelokimab in moderate-to-severe hidradenitis suppurativa had successfully enrolled 210 patients, ahead of schedule. This milestone marks significant progress in the development of next-generation therapies for inflammatory diseases like HS.

List of the Key Players in the Hidradenitis Suppurativa Market:

Pfizer Inc., Eli Lilly and Company, AbbVie Inc., UCB S.A., Incyte Corporation, Novartis AG, Boehringer Ingelheim, Aclaris Therapeutics, Inc., InflaRx N.V., and Moonlake Immunotherapeutics among others.

Research Process:

Both primary and secondary data sources have been used in the global Hidradenitis Suppurativa Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/hidradenitis-suppurativa-market

Segment Covered in the Hidradenitis Suppurativa Market:

By Clinical Stage: Hurley Stage 1, Hurley Stage 2, Hurley Stage 3.

By Skin Condition: Folliculitis, Pimples, Boils, Deep-Acne, Others.

By Treatment Type: Surgery, Medications, Photodynamic Therapy (PDT), Laser Treatment, Others.

By Route of Administration: Oral, Parenteral, Others.

By End-user: Hospitals, Specialty Clinics, Homecare, Others.

By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others.

Regional Analysis for Hidradenitis Suppurativa Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the Hidradenitis Suppurativa Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Hidradenitis Suppurativa market?

➠ Who are the top manufacturers in the global Hidradenitis Suppurativa industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Hidradenitis Suppurativa market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Hidradenitis Suppurativa market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Hidradenitis Suppurativa industry landscape?

Browse More Reports: https://www.datamintelligence.com/research-report/hidradenitis-suppurativa-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.